Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2

Model NO.
Tirzepatide
Shipping
FedEx, DHL, EMS, TNT, 4px, Royal Postal, Aramex
Payment
Debit Card, Btc, Wu, Moneygram, T/T
UK Warehouse
Shipping Within 48hrs
Shelf Life
24month
Storage
Keep Dry and Away From Light.
Certificate
GMP, HPLC, COA, MSDS
CAS No
2023788-19-2
Application
Weight Loss, Obesity Drug
Grade Standard
10mg/15mg
Trade Name
Ly3298176
Product Name
Tirzepatide
Transport Package
10mg
Specification
99%
Trademark
Niche
Origin
China
HS Code
2935900090
Production Capacity
100000vials/Month
Reference Price
$ 72.00 - 90.00
Contact Us

Product Description

Novel long-term weekly half-life weight loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK warehouse CAS:2023788-19-2
Product Description

Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2

Detailed Product Information
 
Product Name : Tirzepatide
Trade Name : LY3298176
CAS No. :2023788-19-2
Purity : 9 8 % HPLC
Appearance:   Lyophilized Powder
Typical use : weight loss peptides
Shelf Life  :2 years
Storage : Refrigeration keep dry and away from light.
 
Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2

Description:

Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. 

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety .   Its half-life of approximately 5 days allows once-weekly subcutaneous administration.   A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.
Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.
We conducted the SURPASS-2 trial (A Study of Tirzepatide [LY3298176] versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants with Type 2 Diabetes) to compare the efficacy and safety of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with those of semaglutide at a dose of 1 mg in patients with type 2 diabetes that had been inadequately controlled with metformin monotherapy.


Rybelsus ( semaglutide ) is used together with diet and exercise to improve blood sugar control in adults with type 2   diabetes mellitus .
Rybelsus is usually given after other diabetes medicines have been tried without success.

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.

Weekly semaglutide 2.4 mg (Wegovy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²

Semaglutide 1 mg injection (Ozempic) was first approved as a treatment for type 2 diabetes in 2023.

Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placebo

Semaglutide 2.4 mg should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs and herbal products, according to the release. Semaglutide 2.4 mg has not been studied in patients with a history of pancreatitis.

This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it. This is another tool that will allow clinicians to better manage obesity.


Function
  • Diabetes Type 2 Medicine
  • Oral GLP-1RA Medication
  • Weight Loss
  • Diabetes Mellitus
  • Obesity
  • Diabetic Coma (in DM Type II)
  • Diabetic Ketoacidosis (in DM Type II)
  • Cardiovascular Risk Reduction
Related Products
 
 
WEIGHT LOSS 
1 Semaglutide( Ozempic ) 910463-68-2 2 Tirzepatide(LY3298176) 2023788-19-2
3 5-Amino 1MQ 42464-96-0 4 Liraglutide(Saxenda) 204656-20-2
5 7-Keto 566-19-8 6 Cetilistat 282526-98-1
7 Synephrine 5985-28-4 8 Rimonabant 168273-06-1
9 Bupropion 34911-55-2 10  L-Carnitine 541-15-1


 
Certifications
 
Appearance White powder.
Purity 99%min
Single Impurity (HPLC)  1.0%max
Amino Acid Composition  ±10% of theoretical
Peptide Content (N%)  ≥80.0%
Water Content(Karl Fischer)  ≤6.0%
Acetate Content (HPIC) ≤15.0%
MS(ESI) Consistent
Mass Balance  95.0~105.0%
Specific Rotation (20/D)  -65.0~-75.0°(c=0.5 1%HAc)
Solubility H 2 O:40 mg / mL
Storage condition -20ºC
Shelf life 2 years

Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2
Packing:
  • Delivery Time:  Around 3-5 workdays after your payment.
  • Package:  In fiber-drums with two-plastic bags inside.
  • N et Weight:  25kgs/Drum / Gross Weight: 28kgs/Drum
  • Drum Size & Volume:  I.D.42cm × H52cm, 0.08 m³/ Drum
  • Storage:  Stored in dry and cool place, keep away from strong light and heat.
  • Shelf Life:  Two years when properly stored.
Shipping:
  • 1, DHL Express, FEDEX and EMS for quantity less than 50KG, usually called as DDU service;
  • 2, Sea shipping for quantity over 500KG; and air shipping is available for 50KG above;
  • 3, For high value products, please select air shipping and DHL express for safe;
  • 4, Please confirm if you can make the clearance when goods reach your customs before placing an order, for buyers from Mexico, Turkey, Italy, Romania,Russia, and other remote area.

Q & A
Q1: How to confirm the Product Quality before placing orders?
A: By sending you our available samples.
Or if you have special requirement on the goods, we can prepare samples according to your requirement for your confirmation.
 
Q2: Can you supply free samples?
A: Yes, we can provide some free sample, but the shipping cost should be on the customers' account. You can either pay the shipping cost or arrange a courier to collect the samples.
 
Q3: What's the MOQ?
A: For the high value product, our MOQ starts from 1g and generally starts from 10g.
For other low value product, our MOQ starts from 100g and 1kg.
 
Q4: How to place order and make payment?
A: You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by TradeManager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.
 
Q5: How do you treat quality complaint?
A: All our products are strictly tested by our QC, and confirmed by QA; unqualified  material will not be released to customer. 
In case any quality problem is confirmed to be caused by us, we will replace the goods or refund your payment immediately.
 
Company Profile

Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2 Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2 Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2 Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2
Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2 Novel Long-Term Weekly Half-Life Weight Loss Therapy Ly3298176 5mg 10mg 15mg Tirzepatide USA UK Warehouse CAS: 2023788-19-2



 

 

Pharmaceutical Intermediate

GOUV.NE, 2023